FDA
-
-
-
-
-
-
-
Theraclion Delivers a Structuring Year in 2025 and Prepares to Scale up
-
-
-
-
-
-
-
Theraclion Reviews Its 2024 Achievements
-
-
-
-
-
-
-
Theraclion Delivers Its 2023 Strategic Objectives
-
-
-
-
-
-
-
FDA Approval for Pivotal Varicose Veins Study With Theraclion’s SONOVEIN®
-
-
-
-
-
-
-
First Patients Treated With Theraclion's SONOVEIN® in the US
-
-
-
-
-
-
-
FDA Approves the 1st Trial with Theraclion's Vein Therapy in the US
-
-
-
-
-
-
-
First European Podium Presentation at Congress of the German Society of Phlebology for Theraclions’ Echopulse for Varicose Veins
-
327,061 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

